• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病性痴呆:当前数据综述

Alzheimer's dementia: current data review.

作者信息

Uzun Suzana, Kozumplik Oliver, Folnegović-Smalc Vera

机构信息

Vrapce Psychiatric Hospital, Zagreb, Croatia.

出版信息

Coll Antropol. 2011 Dec;35(4):1333-7.

PMID:22397284
Abstract

The review focuses on current data on Alzhemier's dementia, a clinical syndrom characterised with acquired deterioration of cognitive functioning and emotional capacities, which impaires everyday activity and quality of life. Alzheimer's dementia is the most common type of dementia in clinical surveys. The diagnosis of Alzheimer's dementia is primarily based on symptoms and signs and memory impairment is clinically most significant. Cholinesterase inhibitors -donepezil, rivastigmine and galantamine are considered to be the first line pharmacotherapy for mild to moderate Alzheimer's disease. Currently, no effective pharmacologic interventions have been researched enough to support their use in prevention of Alzheimer's dementia. Studies suggest that healthy lifestyle, ongoing education, regular physical activity, and cholesterol control, play a role in prevention of Alzheimer's dementia.

摘要

这篇综述聚焦于阿尔茨海默病性痴呆的当前数据,这是一种临床综合征,其特征为认知功能和情感能力的后天性衰退,会损害日常活动和生活质量。在临床调查中,阿尔茨海默病性痴呆是最常见的痴呆类型。阿尔茨海默病性痴呆的诊断主要基于症状和体征,其中记忆障碍在临床上最为显著。胆碱酯酶抑制剂——多奈哌齐、卡巴拉汀和加兰他敏被认为是轻至中度阿尔茨海默病的一线药物治疗方法。目前,尚未对足够有效的药物干预措施进行研究以支持其用于预防阿尔茨海默病性痴呆。研究表明,健康的生活方式、持续学习、规律的体育活动和胆固醇控制在预防阿尔茨海默病性痴呆中发挥作用。

相似文献

1
Alzheimer's dementia: current data review.阿尔茨海默病性痴呆:当前数据综述
Coll Antropol. 2011 Dec;35(4):1333-7.
2
Recommendations for best practices in the treatment of Alzheimer's disease in managed care.管理式医疗中阿尔茨海默病治疗的最佳实践建议。
Am J Geriatr Pharmacother. 2006;4 Suppl A:S9-S24; quiz S25-S28. doi: 10.1016/j.amjopharm.2006.10.001.
3
The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.专家共识指南系列。痴呆及其行为障碍的治疗。引言:方法、评论与总结。
Postgrad Med. 2005 Jan;Spec No:6-22.
4
Current treatments for Alzheimer's disease: cholinesterase inhibitors.阿尔茨海默病的现有治疗方法:胆碱酯酶抑制剂。
J Clin Psychiatry. 2003;64 Suppl 9:11-7.
5
Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention.阿尔茨海默病行为症状的治疗策略:聚焦早期药物干预
Pharmacotherapy. 2007 Mar;27(3):399-411. doi: 10.1592/phco.27.3.399.
6
Effective pharmacologic management of Alzheimer's disease.阿尔茨海默病的有效药物治疗
Am J Med. 2007 May;120(5):388-97. doi: 10.1016/j.amjmed.2006.08.036.
7
[Treatment of Alzheimer's disease: the current situation?].[阿尔茨海默病的治疗:现状如何?]
Rev Med Brux. 2010 Sep;31(4):357-62.
8
Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population.多奈哌齐、卡巴拉汀、加兰他敏和美金刚用于治疗成年唐氏综合征患者阿尔茨海默病性痴呆的综述:对智力残疾人群的启示
Int J Geriatr Psychiatry. 2004 Jun;19(6):509-15. doi: 10.1002/gps.1077.
9
Alzheimer's disease: beware of interactions with cholinesterase inhibitors.阿尔茨海默病:谨防与胆碱酯酶抑制剂的相互作用。
Prescrire Int. 2006 Jun;15(83):103-6.
10
[Pharmacological therapy in Alzheimer's disease. Current clinical practice in The Netherlands].[阿尔茨海默病的药物治疗。荷兰的当前临床实践]
Tijdschr Gerontol Geriatr. 2005 Jul;36(3):122-6.

引用本文的文献

1
Integrated Network Pharmacology and Comprehensive Bioinformatics Identifying the Mechanisms and Molecular Targets of Yizhiqingxin Formula for Treatment of Comorbidity With Alzheimer's Disease and Depression.整合网络药理学与综合生物信息学方法探究益智清心方治疗阿尔茨海默病合并抑郁症共病的作用机制及分子靶点
Front Pharmacol. 2022 Apr 25;13:853375. doi: 10.3389/fphar.2022.853375. eCollection 2022.
2
Association of Acute Kidney Injury with the Risk of Dementia: A Meta-Analysis.急性肾损伤与痴呆风险的关联:一项荟萃分析。
J Clin Med. 2021 Sep 26;10(19):4390. doi: 10.3390/jcm10194390.
3
Intranasal administration of dauricine loaded on graphene oxide: multi-target therapy for Alzheimer's disease.
载道诺林的鼻腔给药:用于阿尔茨海默病的多靶点治疗。
Drug Deliv. 2021 Dec;28(1):580-593. doi: 10.1080/10717544.2021.1895909.
4
ginseng as an adjuvant treatment for Alzheimer's disease.人参作为阿尔茨海默病的辅助治疗手段。
J Ginseng Res. 2018 Oct;42(4):401-411. doi: 10.1016/j.jgr.2017.12.008. Epub 2018 Jan 12.
5
A Complex Relationship Between Suicide, Dementia, and Amyloid: A Narrative Review.自杀、痴呆症与淀粉样蛋白之间的复杂关系:一篇叙述性综述
Front Neurosci. 2018 Jun 1;12:371. doi: 10.3389/fnins.2018.00371. eCollection 2018.
6
Curcumin Treatment is Associated with Increased Expression of the N-Methyl-D-Aspartate Receptor (NMDAR) Subunit, NR2A, in a Rat PC12 Cell Line Model of Alzheimer's Disease Treated with the Acetyl Amyloid-β Peptide, Aβ(25-35).姜黄素治疗与阿尔茨海默病大鼠 PC12 细胞系模型中 N-甲基-D-天冬氨酸受体(NMDAR)亚单位 NR2A 的表达增加有关,该模型用乙酰淀粉样β肽,Aβ(25-35)处理。
Med Sci Monit. 2018 May 1;24:2693-2699. doi: 10.12659/MSM.906933.
7
Long-term risk of dementia following acute kidney injury: A population-based study.急性肾损伤后痴呆的长期风险:一项基于人群的研究。
Tzu Chi Med J. 2017 Oct-Dec;29(4):201-207. doi: 10.4103/tcmj.tcmj_40_17.
8
Neuroprotective effects of phenylethanoid glycosides in an model of Alzheimer's disease.苯乙醇苷在阿尔茨海默病模型中的神经保护作用。
Exp Ther Med. 2017 May;13(5):2423-2428. doi: 10.3892/etm.2017.4254. Epub 2017 Mar 22.
9
Predictability of Social-anamnestic Variables on Receptive Vocabulary and Cognitive Functioning of the Elderly Population.社会记忆变量对老年人群接受性词汇和认知功能的可预测性
Mater Sociomed. 2016 Dec;28(6):424-428. doi: 10.5455/msm.2016.28.424-428.
10
Edaravone ameliorates oxidative damage associated with Aβ25-35 treatment in PC12 cells.依达拉奉可改善 Aβ25-35 处理的 PC12 细胞中的氧化损伤。
J Mol Neurosci. 2013 Jul;50(3):494-503. doi: 10.1007/s12031-013-9973-z. Epub 2013 Feb 8.